NCT06103058 is a clinical trial of Cross sectional in Fibromyalgia, sponsored by Mutah University.

Who is sponsoring NCT06103058?

NCT06103058 is sponsored by Mutah University.

What drugs are being tested in NCT06103058?

Interventions in NCT06103058: Cross sectional.

What condition does NCT06103058 study?

NCT06103058 studies Fibromyalgia, Orthopedic Disorder.

Is NCT06103058 still recruiting?

NCT06103058 is currently status unknown. Last updated 26 October 2023.

Last reviewed 2023-10-26 · How we verify

NCT06103058

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Prevalence of Fibromyalgia in Adults at Al-Karak Jordan a Cross-sectional Study

Status unknown Last updated 26 October 2023

What this trial tests

trial testing Cross sectional in Fibromyalgia in 965 participants. Status unknown.

Timeline

12 May 2023

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	Mutah University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	965
Start date	12 May 2023
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across Jordan

Drugs / interventions tested

Cross sectional

Conditions studied

Fibromyalgia — all drugs for Fibromyalgia →
Orthopedic Disorder — all drugs for Orthopedic Disorder →

Sponsor

Mutah University

Who can join

Adults 1 Month to 100, any sex, with Fibromyalgia or Orthopedic Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Fibromyalgia is a chronic and intricate musculoskeletal disorder characterized by widespread pain, fatigue, and tenderness in specific anatomical regions. Although its prevalence varies among populations, understanding the prevalence in different geographical areas is crucial for healthcare planning. This cross-sectional study aims to determine the prevalence of fibromyalgia in adults residing in Al-Karak, Jordan. The city's unique demographic and environmental characteristics may influence the occurrence of fibromyalgia among its adult population. The study aims to address gaps in knowledge, provide localized insights, and shed light on fibromyalgia's burden on the community's health. Accurate prevalence data aids healthcare planning and resource allocation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The prevalence of fibromyalgia in adults at Al-Karak Jordan: a cross-sectional study.
Akel A, Sarhan MY, Dwairy MA, Al-Zu'bi B, et al · · 2024 · cited 1× · PMID 38463111 · DOI 10.1097/ms9.0000000000001722

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
NCT07245303 — Neural Mechanisms of Light Driven Analgesia · NA · recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
NCT07465991 — The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia · NA · recruiting

Other Mutah University trials

Trials by the same sponsor.

NCT06765382 — Association of Vitamin D Intake, and Associated Factors with Low Back Pain: a Retrospective Cohort Study · completed
NCT05581264 — Diabetes Self-Management Educational Program · NA · completed
NCT05229796 — Pharmacokinetics and Bioequivalence of Two Empagliflozin, With Evaluation in Healthy Jordanian Subjects Under Fasting an · NA · completed
NCT04336280 — Detrusor Underactivity: Presentation and Urodynamic Characteristics · completed
NCT04309890 — Arabic Translation and Validation of the (Overactive Bladder Symptom Score) OABSS · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06103058 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mutah University
Last refreshed: 26 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06103058.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing